Cooke’s mandate extended at EMA

EMA’s management board has unanimously decided to renew Emer Cooke’s term as executive director through April 30, 2027, Cooke said in a post on LinkedIn. “It is an exciting time for medicines regulation and there will be a huge amount of work to be done as we prepare for the implementation of the new pharma legislation in a time of huge technological change and geopolitical uncertainty,” wrote Cooke, who took on the executive director role in 2020, steering the agency through the pandemic.

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) hired Rhonda Pacheco as president of its U.S. business unit. Pacheco, who joins from Eli Lilly and Co. (NYSE:LLY) where she was group VP of U.S. Lilly cardiometabolic health, will succeed Julie Kim, who will become president and CEO of the Japanese pharma next June. Until then, Kim will serve as interim head of the global portfolio division. ...